Literature DB >> 6852130

Turnover of hyaluronate in the aqueous humour and vitreous body of the rabbit.

U B Laurent, J R Fraser.   

Abstract

Sodium hyaluronates with molecular weights of 18000, 500000 and 4 x 10(6), labelled with either 3H or 14C, were injected into the anterior chamber or into the centre of the vitreous body of rabbits and their rates of disappearance were followed. The out-flow from the anterior chamber in anaesthetized animals was virtually independent of the molecular weight indicating that the disappearance of the polysaccharide is controlled by bulk flow. The rate constant for the disappearance of sodium hyaluronate was 0.0094/min and after treatment with indomethacin 0.0061/min. These figures are in general agreement with published flow-rates of aqueous humour in the rabbit. The disappearance from the vitreous body was strongly molecular weight dependent indicating a diffusion controlled transport. The rate constant for hyaluronate with mean molecular weight of 18000 was 0.16/day and 500000, 0.024/day. The rate constant for endogenous hyaluronate was estimated to be about 0.01/day. A calculation using these rate constants shows that the turnover of sodium hyaluronate in the rabbit anterior chamber is about 3 micrograms per 24 hr while the turnover in the vitreous body is only 15% of that. This confirms an earlier conclusion (Laurent and Granath, 1983) that the preponderant part of the hyaluronate in aqueous humour is not a general degradation product from the vitreous body.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6852130     DOI: 10.1016/0014-4835(83)90043-x

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  13 in total

1.  Extended Pharmacokinetic Model of the Rabbit Eye for Intravitreal and Intracameral Injections of Macromolecules: Quantitative Analysis of Anterior and Posterior Elimination Pathways.

Authors:  Marko Lamminsalo; Ella Taskinen; Timo Karvinen; Astrid Subrizi; Lasse Murtomäki; Arto Urtti; Veli-Pekka Ranta
Journal:  Pharm Res       Date:  2018-05-31       Impact factor: 4.200

2.  Hyaluronan synthase immunoreactivity in the anterior segment of the primate eye.

Authors:  M Rittig; C Flügel; P Prehm; E Lütjen-Drecoll
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-06       Impact factor: 3.117

3.  Inflow and outflow relations after intraocular fluid-Healon exchange in a case of chronic ocular hypotension.

Authors:  F Koerner; P Niesel; H König
Journal:  Int Ophthalmol       Date:  1985-11       Impact factor: 2.031

4.  Estimation of Intra-vitreal Half-Lifes in the Rabbit Eye with Semi-mechanistic Equations.

Authors:  Walter Schmitt
Journal:  Pharm Res       Date:  2016-09-14       Impact factor: 4.200

5.  Gene and protein expression pilot profiling and biomarkers in an experimental mouse model of hypertensive glaucoma.

Authors:  Molly M Walsh; Haiqing Yi; Julie Friedman; Kyoung-In Cho; Nomingerel Tserentsoodol; Stuart McKinnon; Kelly Searle; Andrew Yeh; Paulo A Ferreira
Journal:  Exp Biol Med (Maywood)       Date:  2009-06-02

6.  An anchoring molecule increases intravitreal retention of antibody-based therapeutics used in the treatment of ocular diseases.

Authors:  Quanqing Gao; Ira H Schachar
Journal:  J Control Release       Date:  2020-08-25       Impact factor: 9.776

Review 7.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

8.  Long-acting protein drugs for the treatment of ocular diseases.

Authors:  Joy G Ghosh; Andrew A Nguyen; Chad E Bigelow; Stephen Poor; Yubin Qiu; Nalini Rangaswamy; Richard Ornberg; Brittany Jackson; Howard Mak; Tucker Ezell; Vania Kenanova; Elisa de la Cruz; Ana Carrion; Bijan Etemad-Gilbertson; Roxana Garcia Caro; Kan Zhu; Vinney George; Jirong Bai; Radhika Sharma-Nahar; Siyuan Shen; Yiqin Wang; Kulandayan K Subramanian; Elizabeth Fassbender; Michael Maker; Shawn Hanks; Joanna Vrouvlianis; Barrett Leehy; Debby Long; Melissa Prentiss; Viral Kansara; Bruce Jaffee; Thaddeus P Dryja; Michael Roguska
Journal:  Nat Commun       Date:  2017-03-23       Impact factor: 14.919

Review 9.  Pursuing Intracellular Pathogens with Hyaluronan. From a 'Pro-Infection' Polymer to a Biomaterial for 'Trojan Horse' Systems.

Authors:  Elita Montanari; Chiara Di Meo; Angela Oates; Tommasina Coviello; Pietro Matricardi
Journal:  Molecules       Date:  2018-04-18       Impact factor: 4.411

10.  Human retinal Müller cells synthesize collagens of the vitreous and vitreoretinal interface in vitro.

Authors:  Theodorus L Ponsioen; Marja J A van Luyn; Roelofje J van der Worp; Hendri H Pas; Johanna M M Hooymans; Leonoor I Los
Journal:  Mol Vis       Date:  2008-03-26       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.